L310-2445 Screening compound: 4-[(5-ethyl-1,2,4-oxadiazol-3-yl)methyl]-6-methyl-7-(1,2,3,4-tetrahydroquinoline-1-sulfonyl)-3,4-dihydro-2H-1,4-benzoxazin-3-one

L310-2445 Screening compound: 4-[(5-ethyl-1,2,4-oxadiazol-3-yl)methyl]-6-methyl-7-(1,2,3,4-tetrahydroquinoline-1-sulfonyl)-3,4-dihydro-2H-1,4-benzoxazin-3-one
L310-2445 Screening compound: 4-[(5-ethyl-1,2,4-oxadiazol-3-yl)methyl]-6-methyl-7-(1,2,3,4-tetrahydroquinoline-1-sulfonyl)-3,4-dihydro-2H-1,4-benzoxazin-3-one alternative view

Chemical Structure Depiction of ChemDiv screening compound L310-2445
4-[(5-ethyl-1,2,4-oxadiazol-3-yl)methyl]-6-methyl-7-(1,2,3,4-tetrahydroquinoline-1-sulfonyl)-3,4-dihydro-2H-1,4-benzoxazin-3-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L310-2445

Molecular Formula

C23H24N4O5S (C23 H24 N4 O5 S)

Compound Name

4-[(5-ethyl-1,2,4-oxadiazol-3-yl)methyl]-6-methyl-7-(1,2,3,4-tetrahydroquinoline-1-sulfonyl)-3,4-dihydro-2H-1,4-benzoxazin-3-one

IUPAC name

4-[(5-ethyl-124-oxadiazol-3-yl)methyl]-6-methyl-7-(1234-tetrahydroquinoline-1-sulfonyl)-34-dihydro-2H-14-benzoxazin-3-one

SMILES

CCc1nc(CN(C(COc2c3)=O)c2cc(C)c3S(N(CCC2)c3c2cccc3)(=O)=O)no1

InChI

InChI=1S/C23H24N4O5S/c1-3-22-24-21(25-32-22)13-26-18-11-15(2)20(12-19(18)31-14-23(26)28)33(29,30)27-10-6-8-16-7-4-5-9-17(16)27/h4-5,7,9,11-12H,3,6,8,10,13-14H2,1-2H3

InChI Key

IFZKALSJXOOJGQ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27244456

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

468.53

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

3.095

Distribution Coefficient, logD

3.095

Water Solubility, LogSw

-3.37

Polar Surface Area

87.826

Acid Dissociation Constant (pKa)

20.50

Base Dissociation Constant (pKb)

-4.44

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

34.80

L310-2445 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

Epitranscriptome Focused Small Molecule Library (20952 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Nervous system
  • Hemic and lymphatic
  • Congenital
  • Metabolic
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with L310-2445 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L310-2445?
Check Price and Availability of L310-2445, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L310-2445 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L310-2445
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L310-2445
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L310-2445 available by request